Zacks Investment ResearchFri, 08 May 2026 16:16:06 GMTAmneal (AMRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)AMRX-3.79%
Zacks Investment ResearchWed, 29 Apr 2026 17:45:25 GMTIs Amneal (AMRX) a Solid Growth Stock? 3 Reasons to Think "Yes"AMRX-3.79%
Zacks Investment ResearchWed, 29 Apr 2026 14:57:12 GMTWall Street Analysts See a 34.77% Upside in Amneal (AMRX): Can the Stock Really Move This High?AMRX-3.79%
Zacks Investment ResearchWed, 29 Apr 2026 14:52:09 GMTAmneal Pharmaceuticals (AMRX) is a Top-Ranked Momentum Stock: Should You Buy?AMRX-3.79%
Zacks Investment ResearchWed, 29 Apr 2026 14:42:55 GMTAre Investors Undervaluing Amneal Pharmaceuticals (AMRX) Right Now?AMRX-3.79%
Zacks Investment ResearchTue, 28 Apr 2026 18:06:21 GMTAmneal 2026-2027 Upside From Biosimilars ScaleAMRX-3.79%
Zacks Investment ResearchTue, 28 Apr 2026 17:27:21 GMTAMRX Growth Drivers: Generics, Biosimilars, and CrexontAMRX-3.79%
Zacks Investment ResearchTue, 28 Apr 2026 17:27:11 GMTAMRX Valuation: What 1.69x Sales Means for InvestorsAMRX-3.79%
Zacks Investment ResearchMon, 27 Apr 2026 14:46:42 GMTHere's Why Amneal Pharmaceuticals (AMRX) is a Strong Growth StockAMRX-3.79%
Zacks Investment ResearchThu, 23 Apr 2026 14:33:01 GMTAMRX Announces Kashiv BioSciences Buyout, Solid Q1 Preliminary ResultsAMRX-3.79%
Zacks Investment ResearchThu, 23 Apr 2026 14:31:54 GMTAmneal (AMRX) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesAMRX-3.79%
Seeking AlphaWed, 22 Apr 2026 19:30:47 GMTAmneal Pharmaceuticals, Inc. (AMRX) Q1 2026 Earnings Call TranscriptAMRX-3.79%
Zacks Investment ResearchWed, 22 Apr 2026 12:21:07 GMTAmneal Pharmaceuticals (AMRX) Q1 Earnings and Revenues Surpass EstimatesAMRX-3.79%
Seeking AlphaTue, 21 Apr 2026 20:59:41 GMTAmneal: A Robust Drug Portfolio Worth Watching, Driving Further Upside PotentialAMRX-3.79%
Zacks Investment ResearchFri, 10 Apr 2026 16:00:24 GMTAMRX: 3 Growth Drivers Behind Amneal's 2026 OutlookAMRX-3.79%
Zacks Investment ResearchFri, 10 Apr 2026 15:55:21 GMTIs AMRX Stock Undervalued? Sales Multiple, Target, UpsideAMRX-3.79%
Zacks Investment ResearchFri, 10 Apr 2026 15:51:06 GMTHere's How AMRX Is Tapping GLP-1 Demand Through ManufacturingAMRX-3.79%
Zacks Investment ResearchFri, 10 Apr 2026 14:46:48 GMTWhy Amneal Pharmaceuticals (AMRX) is a Top Growth Stock for the Long-TermAMRX-3.79%
Seeking AlphaTue, 10 Mar 2026 21:40:19 GMTAmneal Pharmaceuticals, Inc. (AMRX) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptAMRX-3.79%
Zacks Investment ResearchMon, 09 Mar 2026 12:16:10 GMTBest Value Stocks to Buy for March 9thAMRX-3.79%